Latest Health News
ACC.26 Highlights Major Cardiology Late-Breaking Trials
The American College of Cardiology's ACC.26 conference features key sessions on March 28-29, 2026, including HI-PEITHO on thrombolysis for pulmonary embolism and CHAMPION-AF on atrial fibrillation treatments. Other trials cover STEMI unloading, high-risk interventions, and transcatheter valve procedures like SURVIV and Tri-Fr.
Attendees can engage in hands-on simulations for ECMO and pulmonary embolism management.
FDA Approves YUVEZZI Dual-Agent Eye Drop for Presbyopia
The FDA approved YUVEZZI (carbachol 2.75% / brimonidine 0.1%) in January 2026 as the first dual-agent presbyopia-correcting ophthalmic solution. Highlighted at SECO 2026 for its innovative ingredients targeting presbyopia.
Education sessions at SECO emphasized AI and tech advancements in eye care.
Alcon Launches TOTAL30 MF Toric Contact Lenses for Astigmatism
Alcon introduced TOTAL30 MF for Astigmatism, the first multifocal toric lens with water gradient technology for astigmatic presbyopes on a monthly schedule. Aimed at improving vision correction for this patient group.
Showcased amid SECO 2026's focus on ocular innovations.
PharmaCare to Cover Menopause Medications Starting March 1
Canada's PharmaCare program begins covering menopause medications from March 1, 2026, enhancing access for affected women. This policy aims to address health needs amid rising discussions on women's health issues.
Part of broader health coverage expansions.
APA Issues Health Advisory on AI Chatbots for Mental Health
The American Psychological Association warns that AI chatbots and wellness apps lack rigorous testing for safe mental health support. Emphasizes need for validated safety measures in digital mental health tools.
Advisory released in early 2026 to guide users and providers.
Denmark Eliminates Mother-to-Child HIV and Syphilis Transmission
Denmark becomes the first EU country to eliminate mother-to-child transmission of HIV and syphilis, as recognized by WHO. This milestone highlights effective public health strategies in maternal care.
WHO praises Denmark's health system achievements.
WHO Director-General Visits Jordan for Health Collaboration
WHO's Tedros visited Jordan to acknowledge progress in health systems, emergency relief, and mental health initiatives. Focuses on strengthening regional health delivery and support.
Underscores global partnerships in crisis response.
Labroots Announces 14th Neuroscience Virtual Event on March 4
Labroots hosts its 14th Annual Neuroscience Virtual Event on March 4, 2026, exploring brain research advancements. Features webinars on cell isolation for therapy and basophil activation testing for allergies.
Includes sessions on functional ultrasound imaging and proteomics in neuroimmunology.
HIMSS 2026 Spotlights Healthcare IT Transformations
HIMSS 2026 convenes global leaders to explore digital health innovations, IT strategies, and networking. Includes panels on security assessments under privilege, like HIPAA risk analysis.
Aims to address vulnerabilities and improve patient outcomes through tech.
Gut Bacteria Sugar Linked to Neurodegeneration
Researchers identify a sugar produced by gut bacteria that drives neurodegeneration, linking microbiome to brain disorders. Published in February 2026, highlighting novel microbiome-brain connections.
Implications for Alzheimer's and related diseases.
New Drug Shows Dramatic Cholesterol Reduction in Phase 3 Trial
A phase three trial demonstrates a new drug significantly lowers cholesterol levels. Results from February 2026 offer potential for cardiovascular health improvements.
Builds on cell and molecular biology advancements.
Viatris sNDA Accepted for Presbyopia Eye Drop
FDA accepts Viatris and Opus Genetics' sNDA for phentolamine ophthalmic solution 0.75% to treat presbyopia. Recent development adds to eye care innovations for aging populations.
Complements other presbyopia treatments like YUVEZZI.